{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:28:02Z","timestamp":1792099682704,"version":"4.4.0"},"reference-count":25,"publisher":"BMJ","issue":"7","funder":[{"name":"Synoptikfonden"},{"DOI":"10.13039\/100008363","name":"The Danish Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Lundbeck Foundation"},{"name":"the Danish Association for vHL patients and their relatives"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec><jats:title>Background and aims<\/jats:title><jats:p>We aimed to determine the frequency of von Hippel-Lindau disease (vHL) as the underlying cause of retinal hemangioblastoma and to estimate retinal hemangioblastoma incidence and prevalence in a national cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Through the national patient register and vHL research database, we identified 81 patients diagnosed with a retinal hemangioblastoma in Denmark between 1977 and 2014. Consent was obtained for 54 living and 10 deceased patients with retinal hemangioblastoma. For each participant, we collected medical records and family information. Almost all (63 of 64) participants were or had previously been tested for mutations in the <jats:italic>VHL<\/jats:italic> gene.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 84% of the participants (54 of the 64) had vHL. Compared with the non-vHL patients, the vHL patients had their first retinal hemangioblastoma at a younger age (22.5 vs 40 years), and were more likely to have an asymptomatic first hemangioblastoma (80% vs 20%). Overall, 76% (41 of 54) of the vHL patients had a family history of vHL, while none of the patients without vHL did. Despite the rarity of the disease, on average more than eight new tumours are diagnosed each year due to multiple tumour development in vHL patients. The estimated prevalence of patients with retinal hemangioblastoma was up to 1 in 73\u2009080 individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the first national study in which almost all participants were genetically tested, vHL was the underlying cause of retinal hemangioblastoma in 84% of cases; more often than previously reported. We recommend that genetic and clinical vHL screening should be performed in all patients with retinal hemangioblastoma.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-310884","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:35:17Z","timestamp":1506990917000},"page":"942-947","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":44,"title":["Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease"],"prefix":"10.1136","volume":"102","author":[{"given":"Marie Louise M\u00f8lgaard","family":"Binderup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Stendell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Galanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Ulrik","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens F","family":"Kiilgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Luise","family":"Bisgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,9,28]]},"reference":[{"key":"2020050713013670000_102.7.942.1","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.ophtha.2006.02.059","article-title":"Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study","volume":"113","author":"Kreusel","year":"2006","journal-title":"Ophthalmology"},{"key":"2020050713013670000_102.7.942.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3844"},{"key":"2020050713013670000_102.7.942.3","doi-asserted-by":"crossref","unstructured":"Decker J , Neuhaus C , Macdonald F , et al . Clinical utility gene card for: von Hippel-Lindau (VHL). Eur J Hum Genet 2014;22.doi:10.1038\/ejhg.2013.180","DOI":"10.1038\/ejhg.2013.180"},{"key":"2020050713013670000_102.7.942.4","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/77.2.1151"},{"key":"2020050713013670000_102.7.942.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2009.01281.x"},{"key":"2020050713013670000_102.7.942.6","first-page":"3067","article-title":"Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study","volume":"43","author":"Dollfus","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713013670000_102.7.942.7","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.33.2.120"},{"key":"2020050713013670000_102.7.942.8","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.117.3.371"},{"key":"2020050713013670000_102.7.942.9","doi-asserted-by":"publisher","DOI":"10.1177\/1403494811401482"},{"key":"2020050713013670000_102.7.942.10","first-page":"B4763","article-title":"Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition","volume":"60","author":"Binderup","year":"2013","journal-title":"Dan Med J"},{"key":"2020050713013670000_102.7.942.11","unstructured":"http:\/\/www.statistikbanken.dk\/statbank5a\/default.asp?w=1920. 1-6-2017."},{"key":"2020050713013670000_102.7.942.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00758-8"},{"key":"2020050713013670000_102.7.942.13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s004170000200","article-title":"Retinal angiomatosis and von Hippel-Lindau disease","volume":"238","author":"Kreusel","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2020050713013670000_102.7.942.14","first-page":"1909","article-title":"Hemangioblastomas of the retina: impact of von Hippel-Lindau disease","volume":"41","author":"Niemel\u00e4","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713013670000_102.7.942.15","doi-asserted-by":"crossref","first-page":"n\/a","DOI":"10.1002\/humu.21219","article-title":"Genetic analysis of von Hippel-Lindau disease","volume":"31","author":"Nordstrom-O\u2019Brien","year":"2010","journal-title":"Hum Mutat"},{"key":"2020050713013670000_102.7.942.16","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.33.4.328"},{"key":"2020050713013670000_102.7.942.17","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.28.7.443"},{"key":"2020050713013670000_102.7.942.18","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91705-Y"},{"key":"2020050713013670000_102.7.942.19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ejhg.2016.173","article-title":"Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark","volume":"25","author":"Binderup","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"2020050713013670000_102.7.942.20","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.8.508"},{"key":"2020050713013670000_102.7.942.21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2350-13-54","article-title":"Identification of 3 novel VHL germ-line mutations in Danish VHL patients","volume":"13","author":"Dandanell","year":"2012","journal-title":"BMC Med Genet"},{"key":"2020050713013670000_102.7.942.22","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.11.2139"},{"key":"2020050713013670000_102.7.942.23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0161-6420(99)90127-6","article-title":"A clinical and molecular genetic analysis of solitary ocular angioma","volume":"106","author":"Webster","year":"1999","journal-title":"Ophthalmology"},{"key":"2020050713013670000_102.7.942.24","doi-asserted-by":"publisher","DOI":"10.1086\/302037"},{"key":"2020050713013670000_102.7.942.25","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.44"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-310884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:55:56Z","timestamp":1601110556000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-310884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,28]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,6,24]]},"published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1136\/bjophthalmol-2017-310884"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310884","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,28]]}}}